Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Businessweek Archives

Suicide Prevention May Get A Biochemical Boost


Developments to Watch

SUICIDE PREVENTION MAY GET A BIOCHEMICAL BOOST

Why does one depressed person struggle through life's darkest moments, while another decides to end it all? New studies by Dr. John Mann of Western Psychiatric Institute in Pittsburgh offer biochemical answers. By examining the brains of suicide victims, Mann has discovered that the levels of a key brain chemical, serotonin, are up to 50% lower in suicide victims than in the brains of people who died in accidents. Similarly, by measuring the metabolic by-products of serotonin in spinal fluid, Mann also has found that serotonin levels are lower than normal in many people who had made serious suicide attempts.

The abnormalities turn up in a region of the brain associated with emotion and the control of impulses, suggesting that a serotonin deficiency might intensify depression or boost thoughts of desperate remedies. If that's so, says Mann, scientists may be able to spot and correct this deficiency, thus preventing many of the 32,000 suicides in the U. S. this year.EDITED BY PAMELA J. BLACK


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus